These effects, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the concept of targeting ACKR3 as a singular approach to modulate the opioid technique, which could open up new therapeutic avenues for opioid-connected disorders. We independently exploration, critique, and https://dereks627ibr3.wikienlightenment.com/user